Skip to Navigation
Company JW KEEPING THE HEALTH AND FUTURE OF HUMANKIND

History

JW Group has started its steps with the restoration of nation’s independence

JW Group’s footstep which has brought about the great accomplishment Represents the history of Korea’s pharmaceutical industry.
  • 2001
    • Awarded the 1st CEO grand prize (Korea CEO Academy)
    • Balofloxacin certified by KFDA
      as Phase Ⅲ shinyak for the first time in Korea
  • 2000
    • Awarded US$10mil Export Tower
    • Theriac Research Corporation established
      (Joint research agreement with PNRI)
  • 1999
    • Hydration solution production exceeded 1 billion bottles
    • Choongwae Information Technology (CIT) established
  • 1998
    • Designated as Good Pharmaceutical company
      (Medical Paper, Ilgan Bosa)
    • Awarded the 5th Foundation Prize (KASBA)
  • 1997
    • Designated as Good Labor-Management relationship company
      (Labor Ministry)
    • Antifungal Itraconazole developed
  • 1995
    • Awarded the 4th Economy Righteousness Enterprise
    • Awarded Industrial Bronze Tower
  • 1994
    • Designated as Good Environment Enterprise for 3 consecutive years
    • Choongwae Chemcal established
    • Arthythima treatment medicine, KCB, developed
  • 1993
    • JW Medical established by meeting
      Choongwae Machinery and Choongwae trading company
  • 1992
    • C&C Research & Lab established
  • 1991
    • Chungmo Pharmaceutical renamed to Daeyoo Pharmaceutical
    • Designated as eligible KGMP company (Health Ministry)
  • 1990
    • Chungmo Pharmaceutical merged
    • Awarded Moran Medal
  • 1988
    • Choongwae Industrial established
  • 1987
    • Choongwae Medical Corp’s Yongin plan completed
    • Designated as KGMP eligible company (Health Ministry)
    • Awarded Moran Medal